Patent ID: 9226918
Filing Date: 2016-01-05
CPC Classification: A61K,A61P

Claim Text:
1. A method for treating physical dependence and/or withdrawal symptoms associated with narcotic use, comprising administering to a human subject in need thereof a pharmaceutical composition consisting essentially of (1) a narcotic compound selected from the group consisting of morphine, hydrocodone, oxycodone, hydromorphone, and oxymorphone, buprenorphine and a combination of buprenorphine and naloxone, wherein said composition is administered at a dose of between 2 and 25 mg/70 kg of subject; and (2) a 5-HT3 receptor antagonist in a dose effective to reduce physical dependence and/or withdrawal symptoms associated with said narcotic use, wherein the narcotic compound and the 5-HT3 receptor antagonist are co-administered.